title: Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer?
abstract: Accurate mediastinal staging is the hallmark of a good thoracic oncology program. Mediastinal lymph node staging is important for prognostication and to guide the administration of neoadjuvant and adjuvant therapy. In addition, accurate mediastinal staging is necessary for a fair comparison of different clinical studies. The most important surgical advance in mediastinal lymph node staging in the past few years is transcervical staging, by either sternal elevation or video-assisted mediastinoscopy. The present report summarizes the existing published data evaluating such an approach.
authors.affiliation: Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Sai
authors.initials: S
authors.lastname: Yendamuri
authors.forename: Todd L
authors.initials: TL
authors.lastname: Demmy
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008197:Lymph Node Excision / Q000379:methods* / Q000592:standards*; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D008481:Mediastinoscopy / Q000592:standards*; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic / Q000592:standards; D011237:Predictive Value of Tests; D011379:Prognosis; D019616:Thoracic Surgical Procedures; D020535:Video-Assisted Surgery / Q000592:standards*